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CRISPR-Cas systems (clustered regularly interspaced short palindromic
repeats/CRISPR-associated proteins) are found in 90% of archaea and about
40% of bacteria. In this original system, CRISPR arrays comprise short, almost unique
sequences called spacers that are interspersed with conserved palindromic repeats.
These systems play a role in adaptive immunity and participate to fight non-self DNA
such as integrative and conjugative elements, plasmids, and phages. In Streptococcus
agalactiae, a bacterium implicated in colonization and infections in humans since
the 1960s, two CRISPR-Cas systems have been described. A type II-A system,
characterized by proteins Cas9, Cas1, Cas2, and Csn2, is ubiquitous, and a type I–C
system, with the Cas8c signature protein, is present in about 20% of the isolates.
Unlike type I–C, which appears to be non-functional, type II-A appears fully functional.
Here we studied type II-A CRISPR-cas loci from 126 human isolates of S. agalactiae
belonging to different clonal complexes that represent the diversity of the species and
that have been implicated in colonization or infection. The CRISPR-cas locus was
analyzed both at spacer and repeat levels. Major distinctive features were identified
according to the phylogenetic lineages previously defined by multilocus sequence
typing, especially for the sequence type (ST) 17, which is considered hypervirulent.
Among other idiosyncrasies, ST-17 shows a significantly lower number of spacers in
comparison with other lineages. This characteristic could reflect the peculiar virulence
or colonization specificities of this lineage.
Keywords: Streptococcus agalactiae, CRISPR-Cas, phylogeny, ST-17, typing
Introduction
Streptococcus agalactiae, or group B Streptococcus (GBS), was ﬁrst described in the late XIXth
century in veterinary medicine as a pathogen causing bovine mastitis (Nocard and Mollereau,
1887). In humans this bacterium emerged in the 1960s and represents currently the leading cause
of neonatal bacterial infections in developed countries (Eickhoﬀ et al., 1964; Mayon-White, 1985;
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Gibbs et al., 2004; Da Cunha et al., 2014). S. agalactiae is
also considered since the 1990s as an emerging pathogen
in elderly subjects with underlying conditions (Farley et al.,
1993; Skoﬀ et al., 2009). Moreover, for 10–30% of the healthy
human population, this bacterium belongs to the commensal
microbiota that colonizes the gastrointestinal and genitourinary
tracts (Hansen et al., 2004; van der Mee-Marquet et al., 2008).
S. agalactiae isolates were initially discriminated on the basis
of the variability of capsular polysaccharides, distinguishing 10
diﬀerent serotypes by agglutination, and more recently by a
molecular approach (Poyart et al., 2007; Imperi et al., 2010).
Among various molecular typing methods multilocus sequence
typing (MLST; Jones et al., 2003), and more recently multiple
locus variable number of tandem repeats analysis (Haguenoer
et al., 2011) were subsequently developed to determine the
genetic relationship among isolates of S. agalactiae and to deﬁne
genogroups associated with peculiar clinical issues. MLST, the
current reference method for S. agalactiae genotyping, is able
to distinguish many sequence types (STs), and methods such as
eburst (Feil et al., 2004) are able to cluster close STs to deﬁne
clonal complexes (CC) reﬂecting the phylogenetic structure
of the S. agalactiae population. Deﬁned phylogenetic lineages
are associated with speciﬁc pathogenicity. In particular, CC-17
constitutes a homogeneous group speciﬁcally adapted to humans
and composed mainly of isolates implicated in the majority
of invasive infections in neonates (Poyart et al., 2008) and
shows a low rate of recombination (Da Cunha et al., 2014).
The others major CC implicated in human infections and/or
colonization are CC-1, CC-10, CC-19, and CC-23 (Bohnsack
et al., 2008). An analysis of sequenced strains representing
the overall species diversity revealed a mosaic organization,
with a core genome containing all the ubiquitous genes, and
a dispensable genome consisting of partially shared and strain-
speciﬁc genes organized in genomic islands (Tettelin et al., 2005).
These genomic islands are formed by integrative and conjugative
elements (ICEs) and prophages (Brochet et al., 2008), suggesting
that horizontal gene transfer plays an important role in genome
diversiﬁcation and in the emergence of virulent clones within
the species. Indeed, the prophage DNA content, accounting
for up to 10% of the dispensable genome, is speciﬁc to each
intraspecies lineage, highlighting a key role for lysogeny on the
evolution of the genetic heritage of bacteria (Domelier et al., 2009;
Salloum et al., 2011). However, bacteriophages (phages) exert
a constant selective pressure on their bacterial hosts, which in
order to survive in this challenging environment have devised
various resistance strategies that viruses are trying to escape
(Labrie et al., 2010). Thus, in most environments, phages, and
bacteria are involved in continuous cycles of co-evolution, in
which the emergence of resistant bacteria helps to preserve
the bacterial lineage, while the rapid emergence of counter-
resistant phages again threatens it. Thus, the investigation of
bacterial resistance mechanisms against viruses is critical for
the understanding of host–pathogen co-evolution (England and
Whitaker, 2013).
Clustered regularly interspaced short palindromic repeats
(CRISPR) and CRISPR-associated proteins (Cas) form the
CRISPR-Cas system which provides adaptive immunity against
invading genetic elements, mainly viruses, ICE, and plasmids,
in many bacteria and most archaea (Barrangou et al., 2007;
Horvath and Barrangou, 2010; Lopez-Sanchez et al., 2012;
Barrangou and Marraﬃni, 2014; Jiang and Doudna, 2015). The
immunity mediated by the CRISPR-Cas system requires the
incorporation of DNA fragments from foreign genetic elements
into CRISPR arrays, that are subsequently transcribed and
processed into small interfering RNAs that guide nucleases
(Cas proteins) for targeting cognate genomes in a sequence-
speciﬁc manner, according to a mechanism which reminds the
mechanism of eukaryotic RNA interference (RNAi). CRISPR
arrays constitute a peculiar family of DNA repeats, ﬁrst described
by Ishino et al. (1987), and usually constituted of multiple, non-
contiguous DNA repeats interspaced by unique sequences of
constant length (21–72 bp), named spacers. Most CRISPR arrays
are ﬂanked on one side by an AT-rich sequence called leader
containing the transcription promoter. The speciﬁcity of this
DNA-encoded immunity is provided by the spacers sequences
that correspond in most cases to segments of captured viral
and plasmid sequences (Bolotin et al., 2005; Mojica et al., 2005;
Pourcel et al., 2005; Horvath et al., 2008). However, a minority
of spacers have been shown to match bacterial chromosome
sequences (Stern et al., 2010; Lopez-Sanchez et al., 2012), and
their function remains unclear. For some species, it has been
demonstrated that such spacers can play a diﬀerent role than
immunity (Louwen et al., 2013). Despite the large diversity of
repeats observed across microbial species (Grissa et al., 2007),
these sequences, typically 23–47 base pairs (bp), have common
properties. Repeats are highly conserved within a given CRISPR
array, although limited sequence divergence can be observed,
notably for the terminal (opposite to the leader end) repeat
(Barrangou et al., 2007; Horvath et al., 2008). Moreover, most
repeats are characterized by their partially palindromic nature
that allows them to form highly conserved secondary structures
(Kunin et al., 2007). Quantitatively, the number of repeat-spacer
units per array varies but remains below 50 units in most
cases, far behind the current record of 588 units observed in
Haliangium ochraceum (Ivanova et al., 2010). Microorganisms
may contain several distinct CRISPR loci, one or two most
frequently, typically located on the chromosome (Mojica et al.,
2005; Grissa et al., 2007). CRISPR arrays are in most cases
adjacent to cas genes that encode a set of functionally very
diverse proteins. These proteins carry functional domains typical
of helicase, polymerase, nuclease, and polynucleotide-binding
proteins (Makarova et al., 2011) and are essential to CRISPR-
Cas system activity (Barrangou et al., 2007; Brouns et al.,
2008; Szczepankowska, 2012). cas genes and the proteins they
encode are diverse but usually highly conserved within a given
CRISPR-Cas type, and thus represent an important criterion
of CRISPR-Cas system classiﬁcation. CRISPR-Cas systems have
been classiﬁed into three types (I–III) and a dozen of subtypes
based on diﬀerences in repeat sequences, Cas protein sequences,
and architecture of cas operons (Makarova et al., 2011). Universal
genes cas1 and cas2, present in all three types, constitute the
core of this classiﬁcation whereas Cas3 nuclease-helicase, Cas9
nuclease, and Cas10 represent the signature proteins for types
I, II, and III, respectively. Phylogenetically, Types I and III
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found both in bacteria and archaea are related, whereas Type
II systems, solely present in bacteria, are distinct (Makarova
et al., 2013). CRISPR-Cas systems function following three
stages (van der Oost et al., 2014), based on the properties
of Cas proteins. The stage called adaptation is characterized
by the integration of a new spacer into the CRISPR array,
which requires Cas1 and Cas2 proteins (Yosef et al., 2012).
New invader-derived spacers are integrated into the CRISPR
array in a polarized manner at the leader end, accompanied
by the duplication of the leader-end (LE) repeat creating a
new repeat-spacer unit (Barrangou et al., 2007). Thus, the
CRISPR array, when considering both content and sequential
order of the spacers, provides a chronological record of past
immune conﬂicts with foreign nucleic acids. The selection of
spacer precursors (called proto-spacers; Deveau et al., 2008)
from the intruding genetic elements appears to be determined
by the recognition of a short ﬂanking sequence (2–5 nt) called
protospacer adjacent motif (PAM), which might be diﬀerent
for each given CRISPR-Cas system (Mojica et al., 2009; Paez-
Espino et al., 2013). During another stage called expression,
a long primary transcript called pre-crRNA is generated from
the CRISPR array (from the transcription promoter embedded
within the leader sequence) and subsequently cleaved within
each repeat sequence by Cas6 nuclease homologs (type I and
III systems) or by RNase III (type II systems), producing
short interfering RNAs called crRNAs. In the third stage called
interference, crRNAs associated with Cas proteins guide Cas
nucleases for speciﬁc cleavage of the target virus or plasmid
sequences.
The adaptive immune system CRISPR-Cas is an acquired
defense mechanism, vertically transmitted. The polymorphism
and highly evolving nature of CRISPR arrays, in conjunction
with their ability to acquire novel spacers in a polarized
manner, make them attractive epidemiological markers for
genotyping, and phylogenetic analysis of microbial populations.
CRISPR array diversity, as a result of both spacer gain (via
polarized spacer acquisition) and loss (via internal deletion
by homologous recombination between two direct repeats) or
error during duplication can be leveraged for genotyping and
phylogenetic analysis of medical interest bacteria (Shariat and
Dudley, 2014). While LE spacers diﬀerentiate closely related
strains separated by small evolutionary time scales, CRISPR
spacer content also provides valuable information about the
common origin of strains when considering the conservation
of ancestral spacers located at the leader-distal end, called
trailer end (TE). An early application of CRISPR spacer
diversity was developed long before the elucidation of CRISPR-
Cas functional role, for typing Mycobacterium tuberculosis
isolates by a hybridization method called spoligotyping (Groenen
et al., 1993). Since then, CRISPR array diversity has been
successfully used for the genotyping of numerous bacterial
species including Yersinia pestis, Corynebacterium diphtheriae,
Pseudomonas aeruginosa, Streptococcus pyogenes, Streptococcus
thermophilus, Campylobacter jejuni, and Salmonella enterica
(Horvath et al., 2013). The investigation of intra-species
polymorphism at CRISPR loci represents a molecular tool
highly promising for the genotyping of many bacteria and the
understanding of their evolution. However, it is important to
keep in mind that the potential typing scheme varies from one
CRISPR locus to another. Indeed, each CRISPR locus has its own
speciﬁcity that conditions its polymorphism: activity (especially
for novel spacer acquisition), distribution and occurrence within
the bacterial species, and its propensity to spread by horizontal
gene transfer. Epidemiologic potential must be assessed for
each bacterial species and each CRISPR locus (Horvath et al.,
2013).
Two CRISPR-Cas systems have been identiﬁed in S. agalactiae,
a type II-A system associated with the CRISPR1 locus, and a
Type I-C system associated with the CRISPR2 locus. Lopez-
Sanchez highlighted the ubiquitous, highly polymorphic, and
functional nature of CRISPR1, whereas CRISPR2, only found in
∼20% of the strains, showed a low degree of diversity, suggesting
little or no activity of the corresponding CRISPR-Cas system
(Lopez-Sanchez et al., 2012). This study reported the use of
CRISPR1 spacer content for genotyping S. agalactiae and, based
on similarities between spacers and known sequences, suggested
a role for the CRISPR1-Cas system in the regulation of the species’
mobilome.
Our work is a continuation of this previous study and focuses
on the analysis of the structure and diversity of CRISPR1 in
S. agalactiae. In addition to the examination of CRISPR1 spacers,
all elements of CRISPR1 (spacers, repeats, and ﬂanking regions)
were integrated in our analysis. The aim of our study was to
apprehend globally the activity and the role of CRISPR1 in order
to assess the pertinence of its use as epidemiological marker and
its involvement in the evolutionary dynamics of the S. agalactiae
species. Our work also diﬀers by the choice of the in silico analysis
method.
Materials and Methods
Bacterial Strains
Our collection consists of 123 epidemiologically unrelated
S. agalactiae strains of human origin collected in various regions
of France during previous epidemiological studies (Domelier
et al., 2008; Table 1). These strains were selected on the
basis of previously established characteristics as representative
of the diversity of strains isolated in humans. Fifty-seven of
them were carriage strains isolated from samples of various
origins (digestive, urogenital, cutaneous, oropharyngeal) in
asymptomatic adult patients. These strains, involved in the
colonization of the commensal ﬂora, were each identiﬁed by a
unique number preceded by the letter “C.” Sixty-six of the 123
S. agalactiae strains were invasive strains isolated in newborns
(n = 37) and adults (n = 29) from normally sterile samples
such as blood cultures (newborns: n = 9, adults: n = 26) and
cerebrospinal ﬂuid (CSF; newborns: n = 28, adults: n = 3). These
strains responsible for invasive diseases were each identiﬁed by a
unique number preceded by the letter “S.” All strains have been
characterized phenotypically and genotypically during previous
studies and their capsular serotype, ST, and prophage DNA
content are known (Salloum et al., 2010, 2011). Moreover three
reference strains of S. agalactiae (NEM316, 2603V/R, and A909)
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which genome has been sequenced and published (Glaser et al.,
2002; Tettelin et al., 2005) were included into our study. The
distribution of strains according to their origins, their capsular
serotype, and ST is presented in Table 1.
DNA Extraction
Streptococcus agalactiae strains were stored at −80◦C in a
medium containing glycerol at a ﬁnal concentration of 20%
(vol/vol), and were grown in trypticase soy agar supplemented
with 5% horse blood (TSH agar, Biomerieux) for 24 h at
37◦C in ambient air. Genomic DNA from each strain was
extracted following enzymatic lysis with mutanolysin (Sigma–
Aldrich). To do so, bacterial suspension of OD600 0.3 was
prepared in a volume of 500 µl of water for extraction (Argene,
Biomerieux) containing 50 U of mutanolysin. Lysis was achieved
by suspension incubation for 1 h at 56◦C followed by 10 min at
100◦C. Lysates were centrifuged at 15000 × g for 3 min, and the
supernatant containing DNA was collected. The concentration of
TABLE 1 | Distribution of the 123 Streptococcus agalactiae strains studied and the three reference strains (NEM316, A909, 2603V/R), as a function of
capsular serotype and origin, within MLST clonal complexes (CC).
Clonal Complex
(No. of strains)
Sequence Type (ST)
(No. of strains)
Capsular serotype
(No. of strains)
No. of invasive strains No. of colonizing
strains
NN Ad
Blood
culture
CSF Blood
culture
CSF
CC-1 (26) ST-1 (16)
ST-2 (5)
ST-173 (1)
ST-196 (3)
ST-370 (1)
V (13) II (2) NT (1)
Ia (1) Ib (1) II (1) NT (2)
V (1)
Ib (1) IV (2)
V (1)
–
–
–
–
–
1
–
–
–
–
6
–
1
–
–
–
–
–
–
–
9
5
–
3
1
– 1 7 – 18
CC-10 (25)
ST-5 (1)
ST-6 (1)
ST-7 (1)
ST-8 (8)
ST-10 (5)
ST-12 (4)
ST-41 (2)
ST-255 (1)
ST-390 (1)
Ib (1)
Ib (1)
NT (1)
Ib (7) NT (1)
Ib (1) IV (1) V (1) NT (2)
Ib (3) III (1)
Ib (3) III (1)
Ib (1)
Ib (1)
–
–
–
–
–
–
–
–
–
–
1
–
1
–
–
–
–
–
–
–
–
1
2
3
–
1
–
–
–
–
–
–
–
–
–
–
1
–
1
6
3
1
2
–
1
2 7 – 15
Strain A909 ST-7 Ia
CC-17 (30) ST-17 (30) III (30) 6 18 1 – 5
CC-19 (14) ST-19 (10)
ST-28 (1)
SR-386 (1)
ST-389 (1)
III (9) NT (1)
V (1)
II (1)
III (1)
–
–
–
–
3
–
–
–
3
–
1
–
1
–
–
–
3
1
–
1
– 3 4 1 5
Strain 2603V/R ST-110 V
CC-23 (26) ST-23 (17)
ST-144 (1)
ST-220 (2)
ST-223 (1)
ST-305 (1)
ST-385 (1)
ST-391 (1)
ST-481 (1)
Ia (15) III (2)
Ia (1)
Ia (2)
Ia (1)
Ia (1)
Ia (1)
III (1)
III (1)
2
–
–
–
–
–
–
1
3
–
–
–
–
–
–
–
5
–
–
–
–
1
–
–
2
–
–
–
–
–
–
–
5
1
2
1
1
–
1
–
3 3 6 2 11
Strain NEM316 ST-23 III
Singletons (5) ST-388 (2)
ST-4 (1)
ST-24 (1)
ST-130 (1)
V (2)
Ia (1)
Ia (1)
V (1)
–
–
–
–
–
–
1
–
–
1
–
–
–
–
–
–
2
–
–
1
– 1 1 – 3
Total 9 28 26 3 57
NN, neonates; Ad, adults; CSF, cerebrospinal fluid.
NT, non-typable.
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the obtained DNA was estimated by spectrophotometry for each
strain.
CRISPR1 Locus Amplification
Polymerase chain reactions (PCRs) for CRISPR1 locus
ampliﬁcation were performed in a T3000 Thermocycler
(Biometra) with Q5 High-Fidelity DNA polymerase R© (New
England Biolabs) and the oligonucleotide pair CRISPR1-PCRF
and CRISPR1-PCRR targeting CRISPR1 ﬂanking regions
(Lopez-Sanchez et al., 2012). PCR ampliﬁcations were performed
in a total volume of 25 µl containing 50 ng of template DNA,
0,5 µM forward and reverse primers, 0,2 mM deoxynucleoside
triphosphates (dNTPs), 2 mM MgCl2, 0,02 U/µl of Q5 High-
Fidelity DNA polymerase R© and 1x buﬀer. The cycling conditions
were as follows: 5 min for denaturation at 98◦C, followed by 40
cycles of 30 s at 98◦C for denaturation, 30 s at 56◦C for annealing,
and 120 s at 72◦C for extension, followed by 10 min at 72◦C
for ﬁnal extension. Positive PCR ampliﬁcation was veriﬁed by
electrophoretic migration into a 1% agarose gel. PCR product
size was estimated by comparison with the molecular weight size
marker “ExactLadder DNAPreMix 2log R©” (Ozyme).
Amplicon Purification and CRISPR1 Locus
Sequencing
All PCR products were puriﬁed using the Centrifugal Filter
Units R© (Millipore Corporation) in accordance with the
manufacturer’s recommendations. The puriﬁed products
were sequenced with BigDyeTerminator R© Mix v3.1 (Applied
Biosystems) and a pair of internal sequencing primers previously
described (Lopez-Sanchez et al., 2012) on a Hitachi 3130xl
Genetic Analyzer (Applied Biosystems). For CRISPR regions
exceeding 1,3 kb, a primer-walking strategy using primers
designed within spacer sequences was performed to complete
sequencing of the PCR products (Supplementary Table S1).
In silico Analysis of CRISPR Loci
The obtained DNA sequences were analyzed, edited, and
assembled using the softwares 4Peaks v1.7.1 (Mekentosj)
and ApE v2.0.47 (Biologylabs). For each sequence, spacers,
repeats, and ﬂanking regions were determined and collected
in a database by using diﬀerent tools speciﬁcally dedicated
to the analysis of CRISPR loci. Initially, CRISPRﬁnder and
CRISPRtionary applications1 (Grissa et al., 2007) were used
to retrieve and ﬁnd the CRISPR1 locus structure, and to
generate dictionary of spacers, respectively. The use of the
CRISPRtionary tool by Lopez-Sanchez allowed the establishment
of a dictionary of 949 spacers, numbered from 1 to 949
(Lopez-Sanchez et al., 2012). New spacers identiﬁed in this
study expanded this dictionary. In a second step, CRISPR1
array structure was determined anew using a macro-enabled
Excel tool named CRISPR database II (P. Horvath, DuPont)
that comprises diﬀerent programs for the identiﬁcation and
extraction of CRISPR features in nucleotide sequences, and
for subsequently establishing a graphic representation of spacer
diversity.
1http://crispr.u-psud.fr
The similarity of each spacer sequence, repeat sequence and
ﬂanking regions to the microbial genome database in GenBank2
was analyzed by BLASTn (Altschul et al., 1997) using an E-value
cut-oﬀ of 0.1. Only matches to elements located outside the
S. agalactiae CRISPR1 array were considered as legitimate hits.
All matches with a bit score above 40.0 and a query cover above
80% (corresponding to 100% identity over at least 24 bp) were
retained. If multiple annotations were proposed, only the top hit
annotation was considered for categorization.
Statistical Analysis
The distribution of the number of spacers with respect to CC was
compared using the non-parametric Kruskal–Wallis test. The test
was considered signiﬁcant for p< 0.05.
Results
Analysis of the CRISPR1 Locus in S. agalactiae
Polymerase chain reaction ampliﬁcation of the CRISPR1 locus
was positive for all the strains, conﬁrming the ubiquitous nature
and conserved structure of the type II-A CRISPR1 locus in
S. agalactiae (Lopez-Sanchez et al., 2012). For each strain a single
DNA amplicon was obtained with a size varying between 1,100,
and 2,700 bp, corresponding to a CRISPR1 array size between
200 and 1,800 bp. The complete sequence of the CRISPR1 locus
could be generated for each strain, which allowed the sequence
analysis of repeats, spacers, leader, and trailer. An overview of the
CRISPR1-cas locus in S. agalactiae is presented in Figure 1.
Analysis of CRISPR Repeats
The typical repeat is conventionally deﬁned as the most
frequent repeat within a CRISPR array. Usually, each CRISPR
array is deﬁned by the sequence of the typical repeat which
is generally highly conserved throughout the array. Among
the 126 strains 1,837 repeats were identiﬁed, including 126
terminal repeats that delimit the distal end of the CRISPR1
array. Analysis of repeats highlighted a highly conserved typical
repeat, present in all strains and representing 92% of the 1,837
repeats identiﬁed, and 98.5% of the internal repeats (Table 2).
The typical repeat is a nearly perfect 36-bp palindrome (5′-
GTTTTAGAGCTGTGCTGTTTCGAATGGTTCCAAAAC-3′)
previously described by Lopez-Sanchez et al. (2012). We analyzed
the typical repeat sequence and investigated similarity to bacterial
sequences using BLASTn and CRISPRdb (Grissa et al., 2007).
The typical repeat showed sequence similarity, according to
predeﬁned criteria (see Material and Methods), to others typical
repeat sequences present in species of the Streptococcus genus.
CRISPR1 typical repeat sequence in S. agalactiae perfectly
matches CRISPR repeats found in S. anginosus, S. infantarius,
S. lutetiensis, and S. gallolyticus ssp. gallolyticus; diverging by
only one nucleotide with CRISPR repeats in S. thermophilus
and S. mutans; and by three nucleotides with CRISPR
repeats in S. pyogenes and S. equi ssp. zooepidemicus.
Clustered regularly interspaced short palindromic repeats1
sequence comparisons showed that although the repeat sequence
2http://www.ncbi.nlm.nih.gov
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FIGURE 1 | Genetic organization of the CRISPR1-cas locus in
Streptococcus agalactiae. cas genes and core genes are shown as black
arrows and blue arrows, respectively. The leader sequence is located between
the cas gene cluster and the CRISPR array (white box; L) while the trailer
sequence is located downstream of the array (white box; T). The direct repeats
(DR) are shown as black diamonds and the terminal repeat, which differs from
the consensus DR, is shown as a white diamond. Spacers are shown as
colored rectangles and unique spacers are represented by unique colors. Below
the CRISPR array, the sequence of the first two repeat-spacer units is shown
with the DRs in black characters and the spacers in color characters.
TABLE 2 | Inventory and distribution of CRISPR1 repeat sequences among S. agalactiae CC.
Type Repeat sequence (5′- 3′) Frequency (%) Clonal complex or ST
(No. of strains)
Internal repeat
Typical repeat GTTTTAGAGCTGTGCTGTTTCGAATGGTTCCAAAAC 98.5 CC-1 (26)
CC-10 (25)
CC-17 (30)
CC-19 (14)
CC-23 (26)
ST-4 (1)
ST-388 (2)
ST-130 (1)
ST-24 (1)
Repeat variants GTTTTAGTGCTGTGCTGTTTCGAATGGTTCCAAAAC 0.1 CC-17 (2)∗
GTTTTAGAGCTGTGCTATTTCGAATGGTTCCAAAAC 0.1 CC-23 (1)∗
GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC 1.2 CC-23 (4)∗
GTTTTAAAGCTGTGCTGTTTCGAATGGTTCCAAAAC 0.1 CC-19 (1)∗
Terminal repeat
Typical terminal repeat GTTTTAGAGCTGTGCTGTTATTATGCTAGGACATCA 52 CC-1 (26)
CC-10 (25)
CC-19 (14)
ST-4 (1)
Terminal repeat variants GTTTTAGAGCTGTGCGGTTATTATGCTAGGGCACCG 25 CC-17 (30)
ST-130 (1)
GTTTTAAAGCTGTGCTGTTATTATGCTAGGGCACCA 21.5 CC-23 (26)
ST-24 (1)
GTTTTAGAGCTGTGCTGTTATTATGCTAGGGCACCA 1.5 ST-388 (2)
Nucleotide polymorphisms as compared to the typical CRISPR repeat sequence are indicated in red.
∗All CRISPR1 arrays with at least a repeat variant contain also the typical repeat.
is usually highly conserved throughout the array, polymorphisms
can be observed. Rare polymorphisms were observed in the
repeat sequence, leading to four variants (or atypical repeats) that
carry single-nucleotide polymorphisms and represent 25 of the
1,837 repeats identiﬁed (1.5%; Table 2). As observed previously
in other organisms, the main repeat polymorphism is located
at the distal end of each CRISPR array, in the terminal repeat.
For all strains, the terminal repeat showed sequence degeneracy
predominantly at the 3′ end of the repeat, marking the boundary
of the CRISPR1 array. We found four diﬀerent terminals repeats
of very similar sequence, showing 50–70% identities with the
typical internal repeat. Interestingly, the distribution of the
strains according to the sequence of their terminal repeat is
almost perfectly correlated with MLST typing results. Strains of
CC CC-17 and CC-23, and of ST-388 (CC26) are characterized
by the presence of a speciﬁc terminal repeat, whereas CRISPR1
arrays of strains grouped into CC-1, CC-19, and CC-10 have the
same terminal repeat.
Analysis of CRISPR1 Flanking Regions
The leader sequence, directly adjacent to the ﬁrst CRISPR1
repeat, was identiﬁed in all the 126 S. agalactiae strains. As
described previously in other organisms, the CRISPR1 leader is
an A/T-rich (63%) sequence, which is highly conserved within
the species. However, the comparison of leader sequences showed
three types of variations of this sequence. The most common
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variation was only observed in CC-10 strains (13 out of 24), where
one nucleotide is missing at the 3′end of the leader sequence.
Other variations, observed in one CC-1 strain, one CC-19 strain,
and one ST-130 strain, were an addition of three nucleotides
or one nucleotide, and a nucleotide substitution at the 3′end
of the leader sequence, respectively (Supplementary Table S2).
The leader sequence showed no similarity (using BLASTn and
CRISPRdb) to other bacterial sequences, suggesting that the
leader sequence is speciﬁc to S. agalactiae.
The sequence of the ﬂanking region located downstream of
CRISPR1 (trailer end) was identiﬁed and strictly conserved in
all (126) S. agalactiae strains. This region is a non-coding, 540-
bp long sequence located between CRISPR1 and the ndk gene
encoding a nucleoside diphosphate kinase. This sequence also
showed no similarity to other bacterial sequences, suggesting
again a CRISPR1 speciﬁcity.
Analysis of CRISPR1 Spacers
Across the 126 S. agalactiae strains analyzed, we identiﬁed
1,714 spacers, of which 450 (26%) were unique. Among these,
258 spacers were previously described by Lopez-Sanchez et al.
(2012), and 192 spacers corresponded to new spacers that were
incrementally numbered following nomenclature.
CRISPR1 Spacer Polymorphism
Investigation of CRISPR1 spacer diversity across 126 S. agalactiae
strains identiﬁed 115 unique spacer arrangements (93%),
indicating that the high polymorphism of CRISPR1 spacers
in both sequence and number provides a higher strain
discrimination capacity than other subtyping techniques such as
MLST, which separates these same strains into only 31 distinctive
STs, as previously described (Lopez-Sanchez et al., 2012). Graphic
representation of spacers across the CRISPR1 array for the 126
S. agalactiae strains is presented in Figure 2.
Spacer polymorphisms were relatively rarely due to spacer size
diﬀerences. The typical spacer size, 30 bp, is highly conserved
(397/418 = 95%), with remaining spacers ranging in size between
28 and 33 bp. A noteworthy exception was a 58-bp spacer
of which the ﬁrst 30 bp and the last 28 bp were identical to
two contiguous known spacers, suggesting that this atypical
spacer resulted from the deletion of the repeat located in-
between.
The number of spacers in each array displays important
variations across the diﬀerent S. agalactiae strains examined, with
an average number of 13.6 spacers per array, and minimum and
maximum numbers of 2 (S47 from CC-10) and 29 spacers (S193
from CC-19), respectively.
In several cases, variations between strains resulted from
CRISPR1 locus microevolution, leading to mere deletion,
addition, or duplication of one or more repeat-spacer units.
There is a pronounced disparity in these phenomena of
microevolution among S. agalactiae strains since some strains
presented microvariations involving a single repeat-spacer unit,
whereas in others large segments appeared deleted or duplicated.
We also occasionally observed discrete changes in sequence
of CRISPR1 spacers, revealing the presence of variant spacers.
Among the 450 distinctive spacers, 25 (6%) have a nucleotide
sequence varying of one or two nucleotides compared to the
sequence of previously identiﬁed spacers. The variations are
mainly located at 5′- and 3′-end nucleotides of the spacers
and are characterized by the gain or loss of a nucleotide at
either end. Rarely variant spacers diﬀered by single nucleotide
polymorphism in the middle of the spacer. These variant spacers
may have a common origin and variations could be due to point
mutations.
Analysis of CRISPR1 Spacer Sequences
We investigated the sequence similarity of these 167 new spacers
(the 25 variant spacers were not included in this analysis) to
phage, plasmid, and bacterial sequences. Among 62 spacers
(37%) showing matches, 40 (64%) showed similarity to viral
sequences, while 2 (3%) were similar to plasmid sequences, and
20 (33%) matched CRISPR-unrelated chromosomal sequences in
S. agalactiae, S. dysgalactiae, or S. parauberis. These potential
chromosomal target sequences were found in only a few isolates
and could correspond to mobile genetic elements (MGEs, i.e.,
ICEs or phages) inserted in bacterial genomes. Overall, taking
into account all 207 matching spacers (out of 450; 46%), the
large majority matches sequences present in one or several of
the complete S. agalactiae genomes, and corresponds most often
to MGEs inserted in these genomes (LambdaSa3, LambdaSa1,
and Phi3396 prophages, and TnGBS2). Spacers not matching
S. agalactiae MGEs matched either MGEs inserted in other
Streptococcus genomes (for instance prophages JX01 and LYG09),
or more rarely the core genome of S. agalactiae. This distribution
is consistent with that previously reported by Lopez-Sanchez et al.
(2012).
CRISPR1-Based Clustering
Streptococcus agalactiae CRISPR1-based genotyping presents
a high discriminatory potential, mainly due to spacer
polymorphism and the presence of distinctive terminal repeat
variants.
We highlighted above the correlation between strain
distribution according to the sequence of their CRISPR1
terminal repeat and their clustering based on MLST (Table 2).
Moreover, a spacer conservation gradient across the CRISPR1
array was observed. In general, identical spacers between
strains occur more frequently at the trailer end of the array
and thus appear relatively stable (“oldest” spacers). In contrast,
spacers located close to the leader showed more variability and
are frequently unique or present in just a few strains (novel
spacers). This observation is in agreement with the mechanism
of insertion of new spacers at the leader end, and with a reduced
propensity of trailer-end spacers (especially the last one) to be
lost through deletion events, since the last repeat is diﬀerent in
sequence (Table 2; Horvath et al., 2008). The identiﬁcation of
a common set of consecutive spacers at the trailer end of the
array in distinct strains implies the existence of a relatively recent
common ancestor for these strains.
Accordingly, in a ﬁrst step the analysis of spacers located
at the trailer end of the array, along with the terminal repeat
allowed the clustering of all 126 S. agalactiae strains into four
groups (Figure 2). In a second step, the analysis of internal
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FIGURE 2 | Graphic representation of CRISPR1 loci for 126
S. agalactiae strains. Internal repeats are not included; only terminal
repeats (RT), the leader and trailer end sequences (last six nucleotides
and first six nucleotide, respectively) and spacers are represented. Each
spacer is represented by a combination of one select character in a
particular front color, on a particular background color. The color
combination allows unique representation of a particular spacer, whereby
squares with similar color schemes (combination of character color and
background color) represent identical spacers, whereas different color
combinations represent distinguishable spacers. Deleted spacers are
represented by crossed squares. Strain names, clonal complexes (CC),
sequence type (ST), and capsular serotype are given on the left. NCC
indicates strains that do not belong to CC according to MLST. NT
indicates strains that are not discriminated on the basis of the variability
of capsular polysaccharides. Strains were arranged according to the
CRISPR1 content. A double line separates CRISPR1 groups. Broken lines
separate distinct subgroups in CRISPR1 groups and a continuous line
separates NCC strains in CRISPR1 groups.
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(more recently acquired, i.e., closer to the LE) spacer composition
separated each group into various subgroups. Comparison
between the distribution of strains across CRISPR1 groups and
their MLST classiﬁcation showed an evident correlation. The
CRISPR1 group aﬃliation, deﬁned by the trailer-end structure of
the array, is closely related to MLST-based CC.
Four trailer-end spacers and a speciﬁc terminal repeat deﬁne
CC-17, two trailer-end spacers and another speciﬁc terminal
repeat deﬁne CC-23, two trailer-end spacers deﬁne CC-10,
and three trailer-end spacers deﬁne CC-1 and CC-19 that
belong to the same CRISPR1 group. However, strains related
to these two latter CCs could be mostly individualized into
two subgroups on the basis of internal spacers composition.
Strains of CC-10, CC-1, and CC-19 have the same CRISPR1
terminal repeat, which is the typical terminal repeat. Note that
the last CRISPR1 group is a singleton and contains two ST-
388 strains characterized by an identical spacer composition and
a speciﬁc terminal repeat. As previously described by Lopez-
Sanchez et al. (2012), in some CRISPR1 groups a concordance
between subgroups and the results of capsular serotyping or
MLST was observed. For example in CC-23, the internal spacer
composition strictly separates serotype III and Ia strains into
two subgroups (Figure 2). Similarly, strains from CC-1 are
split into four subgroups, distinguishing ST-196 from the other
major STs (ST-2 and ST-1). In some cases CRISPR1 typing was
able to successfully discriminate strains that were considered
indistinguishable by MLST. The homogeneous phylogenetic
lineage composed exclusively of ST-17 strains (capsular serotype
III) appears separated into distinctive subgroups. It is important
to note that three strains (out of 5) that do not belong
to CC according to MLST turn out to be related to CC-
17 (C87: ST-130), CC-23 (S167: ST-24), and CC-1 or CC-19
(S146: ST-4) on the basis of CRISPR1 composition. Among the
126 S. agalactiae strains, only ST-388, constituting a distinct
CRISPR1 group, appears isolated in the CRISPR1-based strain
distribution.
In-depth analysis of the spacer composition reveals a marked
diﬀerence in diversity among subgroups. For some subgroups,
the CRISPR1 spacers close to the leader are relatively preserved
and common to other strains within the same subgroup,
suggesting a reduced ability to further acquire novel spacers. In
others subgroups a higher spacer diversity is observed at the
leader end, while internal spacers seem to have been deleted
en bloc, suggesting a possible link between spacer acquisition
propensity and loss of relatively ancient spacers.
Remarkably, the CRISPR1 analysis reveals diﬀerent levels of
polymorphism among CC as deﬁned by MLST. CC-17 showed
the lowest diversity, followed by CC-23 and the three CC CC-1,
CC-19, and CC-10 (Figure 2). The proportion of unique spacer
arrangements is greater than 90% for all the CCs, except for CC-
17 (80%). Overall, the degree of polymorphism was the lowest for
CC-17 in terms of unique spacers, unique spacer arrangements,
and average spacer number (Figure 3).
Discussion
Analysis of the structure and content of the CRISPR1 locus
in 126 S. agalactiae strains conﬁrmed its ubiquitous nature
despite a high spacer sequence polymorphism, as described by
Lopez-Sanchez et al. (2012). Our results, using a methodology
allowing a careful analysis of the ﬂanking regions, repeats, and
spacers of the CRISPR1 locus, provide additional evidence that
CRISPR1 typing not only correlates strongly with MLST, but
also provides deeper discrimination than the current reference
method for S. agalactiae typing. Variations in CRISPR1 spacer
content were already credited to various mechanisms such as
acquisition, deletion, and internal duplication of one or several
FIGURE 3 | Number of spacers per locus, represented in box plots,
among different CC. The red line is the median. The lower end and the upper
end of the rectangle represent the first and third quartile, respectively. The blue
and green lines represent maximum and minimum values, respectively. The
number of spacers in locus CRISPR1 was significantly lower for strains
belonging to CC-17 than for others CC (∗p < 0.001).
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repeat-spacer units. In addition to these alteration causes, we
identiﬁed the occasional presence of variant spacers likely due to
point mutations, and more importantly the systematic presence
of a degenerated terminal repeat (and the associated, previously
missed upstream spacer) which sequence deﬁnes groups that
match perfectly MLST-based clustering.
The polymorphism observed in spacer content of a CRISPR
array is considered to be an indicator of the functional activity
of the locus. The ubiquitous presence of this CRISPR-Cas system
in the species, the low level of repeat sequence polymorphism,
with the exception of terminal repeats, the absence of insertion
sequences, the conservation of ﬂanking regions, and the
spacer size homogeneity are other arguments in favor of
CRISPR1 activity, as previously described for CRISPR loci in
S. thermophilus (Horvath et al., 2008). Indeed, the interference
eﬀectiveness of S. agalactiae A909 CRISPR1-Cas system was
demonstrated in laboratory conditions under a selective pressure
of TnGBS2, an ICE originating from S. agalactiae NEM316
(Lopez-Sanchez et al., 2012).
The tight congruence between MLST and CRISPR1-based
genotyping highlights the usefulness of the CRISPR1 locus as
an eﬀective epidemiological marker in S. agalactiae. CRISPR-
based typing methods have been well established for some
bacterial species such asM. tuberculosis (Lanotte, 2012) and have
been extended to many other human pathogens, as illustrated
by their application to recent Salmonella enterica epidemic
episodes (Fabre et al., 2012; Shariat et al., 2013). Most often
CRISPR-based typing methods provide discriminatory power
and epidemiological concordance that are at least equivalent, if
not superior, to the commonly used typing methods (Shariat and
Dudley, 2014). However, it is essential to assess, on a case-by-case
basis, the characteristics of any given CRISPR locus before its use
as an epidemiological marker. Actually not all CRISPR loci are
appropriate for molecular subtyping, as illustrated by CRISPR2
in Escherichia coli which has been widely disseminated through
horizontal transfer, altering the epidemiological concordance and
therefore prohibiting its use as typing target (Touchon et al.,
2011).
Beyond strain diﬀerentiation, high-resolution CRISPR1
typing provides opportunities to improve our perception of
S. agalactiae population evolution and to explore the species’
genetic diversity. The existence of strong similarity between the
typical CRISPR1 repeat sequence and CRISPR repeats in many
other streptococcal species such as S. pyogenes and S. anginosus
suggests a wide distribution of this type II-A CRISPR-Cas system
within the genus.
Analysis of the S. agalactiae genome showed a mosaic
organization formed by large chromosomal fragments from
diﬀerent ancestors, suggesting that large DNA exchanges have
contributed to genome dynamics in the natural population
(Brochet et al., 2009). A model has been proposed for the
evolutionary history of this species, in which emergence of CC of
clinical importance could be linked to selective sweeps associated
with the reduction of genetic diversity (Brochet et al., 2009).
The CC-1 and CC-10 strains are characterized by extensive
genetic diversity, in contrast to CC-23 and particularly CC-17
strains.
Interestingly, CRISPR1 analysis of the S. agalactiae population
revealed diﬀerent degrees of heterogeneity among CC. Indeed,
the two CRISPR1 groups containing CC-1/CC-19 and CC-
10 strains are characterized by the same terminal repeat and
appear more heterogeneous, as evidenced by their separation
into many subgroups. Conversely, CRISPR1 groups containing
CC-17 and CC-23 strains seem more homogeneous and are
characterized by a diﬀerent, speciﬁc terminal repeat. Moreover,
they are characterized by a smaller number of spacers, especially
for CC-17. CRISPR1 spacer composition and diversity could
reﬂect this evolutionary history in which clones emerging from
a heterogeneous population would be distinguished by a more
homogeneous CRISPR1 array and the presence of a speciﬁc
terminal repeat.
The CRISPR1 array characteristics could therefore lead to
the development of concrete applications for investigating the
transmission mode (horizontal or vertical) of neonatal bacterial
infections or the source of a contamination, or for the rapid
detection of a particular lineage such as “hypervirulent” ST-17
strains. In fact, CRISPR1 sequence analysis provides a “one-
shot” approach for typing, with the beneﬁts of much-reduced
time and cost compared to MLST. Invasive infections in elderly
adults are characterized for 5% of cases by episodes of recurrent
infections associated with the same strain, requiring the search
for a deep infection localization (Farley, 2001). In this case, the
comparison of two isolates responsible for distinct infectious
events by CRISPR1 sequencing could be a valuable alternative to
MLST to diﬀerentiate recurrent infections from reinfection. For
instance, a PCR assay targeting speciﬁc CRISPR1 spacers could
be developed for this purpose, analogously to the multiplex PCR
assay used for the detection of Salmonella serovar Typhi and
Salmonella serovar Paratyphi A (Shariat and Dudley, 2014). In
another approach the terminal repeat polymorphisms that are
group-speciﬁc could be leveraged by high-resolution melt DNA
(HRM) to rapidly diﬀerentiate alleles, as previously described for
Campylobacter strains (Price et al., 2007).
Despite the high discriminatory power, reproducibility,
portability, and epidemiological concordance of CRISPR1 typing,
limitations exist for its use in diagnostic, epidemiologic, and
evolutionary analyses of S. agalactiae strains. The occasional
absence (due to internal deletion) of group- or subgroups-speciﬁc
spacers prevents or reduces the typing resolution and decreases
the congruence with MLST. This limit is especially important to
consider for strains of CC-1 and CC-19 that are classiﬁed into
the same CRISPR1 group. However, our analysis, providing a
snapshot of CRISPR1 array content and reﬂecting its dynamism,
suggests that these events minimally impact the eﬀectiveness of
CRISPR1 typing.
The selective advantage provided by CRISPR-Cas systems is
controversial, some evolutionary models suggesting that their
main advantage is resistance against lytic phages (Levin, 2010;
Touchon et al., 2011). Paradoxically, similarity searches with
S. agalactiae spacer sequences against the GenBank database
highlighted a large proportion of spacers targeting MGEs
widespread among S. agalactiae genomes. Accordingly, Lopez-
Sanchez proposed that CRISPR1 is selected for at the population
level to ensure the coexistence of carrier and non-carrier strains,
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thus preserving the diversity of the S. agalactiae mobilome
(Lopez-Sanchez et al., 2012).
Conclusion
Our work identiﬁed new sources of diversity within the
CRISPR1 array notably a degenerate terminal repeat delineating
a previously missed spacer, and showed the conservation
of other structural elements such as the typical repeat.
All CRISPR1 features described here are valuable for the
epidemiological typing of S. agalactiae, providing a superior
discriminatory power than MLST. We propose that the
content and diversity of the CRISPR1 array reﬂect the
evolutionary process determining population structure, making
the sequencing of this locus an attractive tool for phylogenetic
studies.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fgene.
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